$32.20
0.672.12%
Last update: Jun 15, 9:57 AM
Phibro Animal Health Corp Analyst Ratings
PAHCNASDAQ
Phibro Animal Health Analyst Ratings and Price Targets | NASDAQ:PAHC | Benzinga
Phibro Animal Health Corp has a consensus price target of $31.67 based on the ratings of 6 analysts. The high is $50 issued by JP Morgan on November 7, 2025. The low is $21 issued by Roth MKM on September 1, 2023. The 3 most-recent analyst ratings were released by Citigroup, Citigroup, and JP Morgan on May 14, 2026, April 15, 2026, and November 7, 2025, respectively. With an average price target of $52 between Citigroup, Citigroup, and JP Morgan, there's an implied 61.49% upside for Phibro Animal Health Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
JP Morgan
B of A Securities
Morgan Stanley
Barclays
1calculated from analyst ratings
Analyst Ratings for Phibro Animal Health
Loading calendar...
FAQ
What is the target price for Phibro Animal Health (PAHC) stock?
The latest price target for Phibro Animal Health (NASDAQ:PAHC) was reported by Citigroup on May 14, 2026. The analyst firm set a price target for $44.00 expecting PAHC to rise to within 12 months (a possible 36.65% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Phibro Animal Health (PAHC)?
The latest analyst rating for Phibro Animal Health (NASDAQ:PAHC) was provided by Citigroup, and Phibro Animal Health maintained their neutral rating.
When was the last upgrade for Phibro Animal Health (PAHC)?
The last upgrade for Phibro Animal Health Corp happened on July 7, 2025 when JP Morgan raised their price target to $35. JP Morgan previously had a neutral for Phibro Animal Health Corp.
When was the last downgrade for Phibro Animal Health (PAHC)?
There is no last downgrade for Phibro Animal Health.
When is the next analyst rating going to be posted or updated for Phibro Animal Health (PAHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phibro Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phibro Animal Health was filed on May 14, 2026 so you should expect the next rating to be made available sometime around May 14, 2027.
Is the Analyst Rating Phibro Animal Health (PAHC) correct?
While ratings are subjective and will change, the latest Phibro Animal Health (PAHC) rating was a maintained with a price target of $62.00 to $44.00. The current price Phibro Animal Health (PAHC) is trading at is $32.20, which is out of the analyst’s predicted range.
